Merck to buy genomic analysis services for 5 yrs from Covance for $145 mn

Covance has entered into a definitive agreement with Merck & Co, Inc relating to the supply of genomic analysis services. Under the terms of the agreement Merck has committed to a five-year $145 million contract to purchase genomic analysis services from Covance. In addition Covance will acquire Merck's Seattle-based Gene Expression Laboratory that performs genomics services such as genotyping, gene sequencing and gene expression profiling.